We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $25B
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+18.87%
3 Year Est. Return
+73.23%
5 Year Est. Return
+90.52%
10 Year Est. Return
+458.69%
AUM
$3.19B
AUM Growth
+$153M
Cap. Flow
+$17.6M
Cap. Flow %
0.55%
Top 10 Hldgs %
29.55%
Holding
324
New
11
Increased
97
Reduced
113
Closed
9

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$27.5M
2
BSX icon
Boston Scientific
BSX
+$25.3M
3
LW icon
Lamb Weston
LW
+$6.07M
4
ADSK icon
Autodesk
ADSK
+$5.95M
5
FCFS icon
FirstCash
FCFS
+$5.8M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$34.4M
2
BKNG icon
Booking.com
BKNG
+$22.2M
3
WEC icon
WEC Energy
WEC
+$7.17M
4
MS icon
Morgan Stanley
MS
+$4.67M
5
INTC icon
Intel
INTC
+$4.26M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Financials 20.16%
3 Healthcare 11.15%
4 Consumer Staples 11.15%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
51
Lockheed Martin
LMT
$117B
$21.1M 0.66%
57,969
-2,408
-4% -$806K
INTC icon
52
Intel
INTC
$491B
$19.4M 0.61%
405,900
-85,876
-17% -$4.26M
XOM icon
53
ExxonMobil
XOM
$615B
$19.4M 0.61%
252,917
-3,633
-1% -$281K
SPY icon
54
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$18.4M 0.58%
62,797
-3,565
-5% -$1.03M
HON icon
55
Honeywell
HON
$71.6B
$18.3M 0.57%
110,932
+5,600
+5% +$891K
RY icon
56
Royal Bank of Canada
RY
$293B
$18.1M 0.57%
227,808
-4,466
-2% -$349K
GLD icon
57
SPDR Gold Trust
GLD
$129B
$18M 0.56%
135,406
+5,006
+4% +$619K
PG icon
58
Procter & Gamble
PG
$347B
$17.5M 0.55%
159,481
-3,551
-2% -$378K
CVX icon
59
Chevron
CVX
$377B
$17.1M 0.54%
137,724
+4,071
+3% +$492K
DFS
60
DELISTED
Discover Financial Services
DFS
$17.1M 0.53%
220,118
-514
-0.2% -$39.8K
ATVI
61
DELISTED
Activision Blizzard
ATVI
$14.5M 0.46%
307,910
-68,891
-18% -$3.16M
XYL icon
62
Xylem
XYL
$28.7B
$14.2M 0.44%
169,361
+12,785
+8% +$1.02M
BNS icon
63
Scotiabank
BNS
$107B
$14.1M 0.44%
261,042
MDLZ icon
64
Mondelez International
MDLZ
$77.2B
$14M 0.44%
259,976
-8,408
-3% -$437K
CL icon
65
Colgate-Palmolive
CL
$73.4B
$13.8M 0.43%
193,067
-2,263
-1% -$161K
MRSH
66
Marsh
MRSH
$87.7B
$11.5M 0.36%
115,158
-2,081
-2% -$199K
AMGN icon
67
Amgen
AMGN
$197B
$11.3M 0.35%
61,145
-32
-0.1% -$5.73K
NTRS icon
68
Northern Trust
NTRS
$33.9B
$11.1M 0.35%
122,977
+2,137
+2% +$197K
AJG icon
69
Arthur J. Gallagher & Co
AJG
$65.4B
$10.4M 0.33%
118,870
-580
-0.5% -$48.4K
CSCO icon
70
Cisco
CSCO
$439B
$10.4M 0.32%
189,541
+37,670
+25% +$2.08M
ULTA icon
71
Ulta Beauty
ULTA
$21B
$9.68M 0.3%
27,911
-1,506
-5% -$520K
LLY icon
72
Eli Lilly
LLY
$1.03T
$8.9M 0.28%
80,314
-1,136
-1% -$134K
SLB icon
73
SLB Ltd
SLB
$69.3B
$8.81M 0.28%
221,827
+11,336
+5% +$457K
PEP icon
74
PepsiCo
PEP
$185B
$8.72M 0.27%
66,504
-857
-1% -$110K
NKE icon
75
Nike
NKE
$64.2B
$8.47M 0.27%
100,881
+3,378
+3% +$284K

Similar funds

Rathbones Group's Q2 2019 Portfolio in Review

As of Q2 2019, Rathbones Group held 324 positions worth $3.19B, up 5% from $3.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Rathbones Group's Q2 2019 filing shows 11 new, 97 increased, 113 reduced and 9 closed positions. Its largest new stake was RingCentral: 238,300 shares worth $27.4M. The largest sale was Abiomed Inc, an estimated $34.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Rathbones Group's largest Q2 2019 buy was RingCentral: 238,300 shares worth $27.4M.
  • Rathbones Group added most to Boston Scientific in Q2 2019, an estimated $25.3M increase.
  • Rathbones Group's biggest Q2 2019 reduction was Abiomed Inc, cutting an estimated $34.4M.
  • Rathbones Group fully exited Goldcorp Inc in Q2 2019, selling an estimated $461K.
  • Rathbones Group's ten largest holdings make up 30% of its $3.19B portfolio in Q2 2019.
  • Rathbones Group opened 11 new positions and closed 9 in Q2 2019.
  • Rathbones Group's portfolio value rose 5% quarter-over-quarter to $3.19B.

Based on Rathbones Group's 13F filing for Q2 2019, filed 12 Aug 2019.